All datasets / xpertsystems
xpertsystems/hconc012-sample
The declared licence (cc-by-nc-4.0) is classified as having use restrictions.
- Declared licence
- cc-by-nc-4.0, from the tagEvidence: README.md at c381f2d
- Licence files
- No licence file at the top level of the repositoryEvidence: file list at c381f2d
- Declared sources
- None listed in the card metadata
- Access gated on Hugging Face
- No
Tasks
Citation text from the card
@dataset{xpertsystems_hconc012_2026,
title = {HC-ONC-012: Multi-Cancer Chemotherapy Response Synthetic Cohort with CTCAE v5.0 Toxicity Grading, RECIST 1.1 / iRECIST Response Assessment, Dose Tracking, and Supportive Care Across 18 Cancer Types and 60+ Regimens},
author = {{XpertSystems.ai}},
year = {2026},
version= {1.0.0},
url = {https://huggingface.co/datasets/xpertsystems/hconc012-sample},
license= {CC-BY-NC-4.0 (sample); Commercial (full product)},
note = {Calibrated against KEYNOTE-189 (Gandhi 2018 pembro+chemo NSCLC), IMpower133 (Horn 2018 atezolizumab+EP SCLC), CASPIAN (Paz-Ares 2019 durvalumab+EP), FLOT-AIO4 (Al-Batran 2019 perioperative gastric), PRODIGE-4 ACCORD-11 (Conroy 2011 FOLFIRINOX pancreatic), MM-VRd (Durie 2017 VRd vs Rd multiple myeloma), CHOP era (Coiffier 2002 R-CHOP DLBCL), POLARIX (Tilly 2022 Pola-R-CHP), BEP era (Williams 1987 bleomycin+etoposide+platinum testicular germ cell), CleopAtrA (Swain 2020 pertuzumab breast), MONARCH-2 (Sledge 2017 abemaciclib breast), KEYNOTE-590 (Sun 2021 pembro esophagogastric), NORDIC-VII (Tveit 2012 FLOX), AIO XELOX-1 (Schmoll 2007), GeparQuinto (von Minckwitz 2014 pCR), CALGB 49907 (Muss 2009), CTCAE v5.0 (NCI 2017), RECIST 1.1 (Eisenhauer 2009), iRECIST (Seymour 2017).}
}
The same facts for your agent
A free MCP server at mcp.datalicense.uk/mcp. Connect it from an MCP client such as Claude or Cursor.
dataset_licence({ "id": "xpertsystems/hconc012-sample" })
signal: "restrictive"
stated_licence: "cc-by-nc-4.0"
sources: 0